The Factors Affecting the Achievement of Glucose Monitor in the Patients on Diabetes

Cognitive Decline Clinical Trial

Official title:

The Effects of Glucose Monitor on Patients With Diabetes

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03804658
• Other study ID #: CG18308A
• Status: Recruiting
• Start date: January 13, 2019
• Est. completion date: December 31, 2024

Study information

• Verified date: October 2020
• Source: Taichung Veterans General Hospital
• Contact: I-Te Lee, MD,PhD
• Phone: +886-4-23592525
• Email: itlee[@]vghtc.gov.tw
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

To assess the effect of glucose monitors on glucose control and cardiovascular risks.

Description:

The investigators will enroll patients with diabetes. The answered questionnaire and blood samples will be collected at baseline. After change the methods or frequency of glucose monitor, the blood samples will be collected again. The investigators will analyze the factors which may affect the glucose control after changes in methods of glucose monitor.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years and older

Eligibility

Inclusion Criteria:

• Adults with diabetes

Exclusion Criteria:

• Incooperative patients

Related Conditions & MeSH terms

• Cognitive Decline
• Cognitive Dysfunction
• Glucose Variability

Intervention

Device:
• Continue glucose monitor system
The cardiovascular risks and data from continue glucose monitor system

Locations

Country	Name	City	State
Taiwan	Division of Endocrinology and Metabolism in Taichung Veterans General Hospital	Taichung

Sponsors (1)

Lead Sponsor	Collaborator
Taichung Veterans General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glucose variability	Data from continue glucose monitor system	3 months
Secondary	brain-derived neurotrophic factor	Biomarker of cognition	3 months
Secondary	Orexin	Biomarker of cognition	3 months
Secondary	Renalase	Biomarker of cognition	3 months
Secondary	Vascular endothelial cell adhesion molecule 1	Biomarker for inflammation	3 months
Secondary	Health Literacy	Questionnaire of health	3 months